WO2000073273A1 - Procede d'obtention de derives 2-halo-3-(3-quinolyl) acide proprionique - Google Patents
Procede d'obtention de derives 2-halo-3-(3-quinolyl) acide proprionique Download PDFInfo
- Publication number
- WO2000073273A1 WO2000073273A1 PCT/JP2000/002001 JP0002001W WO0073273A1 WO 2000073273 A1 WO2000073273 A1 WO 2000073273A1 JP 0002001 W JP0002001 W JP 0002001W WO 0073273 A1 WO0073273 A1 WO 0073273A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- general formula
- derivative represented
- quinolyl
- formula
- quinoline
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 10
- -1 3-quinolyl Chemical group 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 20
- PDVKRIXEUOTSJQ-UHFFFAOYSA-N 3-quinolin-3-ylpropanoic acid Chemical class C1=CC=CC2=CC(CCC(=O)O)=CN=C21 PDVKRIXEUOTSJQ-UHFFFAOYSA-N 0.000 claims description 10
- 125000005843 halogen group Chemical group 0.000 claims description 10
- BLTDCIWCFCUQCB-UHFFFAOYSA-N quinoline-3-carboxamide Chemical class C1=CC=CC2=CC(C(=O)N)=CN=C21 BLTDCIWCFCUQCB-UHFFFAOYSA-N 0.000 claims description 10
- YBIWIEFOLKWDNV-UHFFFAOYSA-N 3-quinolin-3-ylprop-2-enoic acid Chemical class C1=CC=CC2=CC(C=CC(=O)O)=CN=C21 YBIWIEFOLKWDNV-UHFFFAOYSA-N 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- RYGIHSLRMNXWCN-UHFFFAOYSA-N quinoline-3-carbaldehyde Chemical class C1=CC=CC2=CC(C=O)=CN=C21 RYGIHSLRMNXWCN-UHFFFAOYSA-N 0.000 claims description 9
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 150000005014 3-aminoquinolines Chemical class 0.000 claims description 5
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 150000003248 quinolines Chemical class 0.000 claims description 5
- 125000001475 halogen functional group Chemical group 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 230000002140 halogenating effect Effects 0.000 claims description 3
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 125000005396 acrylic acid ester group Chemical group 0.000 claims 1
- 125000001979 organolithium group Chemical group 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 239000007858 starting material Substances 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- AZKFGOQRYCSQPK-UHFFFAOYSA-N 5-[(7-phenylmethoxyquinolin-3-yl)methyl]-1,3-thiazolidine-2,4-dione Chemical compound S1C(=O)NC(=O)C1CC1=CN=C(C=C(OCC=2C=CC=CC=2)C=C2)C2=C1 AZKFGOQRYCSQPK-UHFFFAOYSA-N 0.000 abstract 1
- JXXKDLFGUNPJJD-UHFFFAOYSA-N 7-hydroxyquinoline-3-carbonitrile Chemical compound C1=C(C#N)C=NC2=CC(O)=CC=C21 JXXKDLFGUNPJJD-UHFFFAOYSA-N 0.000 abstract 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 239000000243 solution Substances 0.000 description 19
- 150000001875 compounds Chemical class 0.000 description 18
- 239000013078 crystal Substances 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 229910052739 hydrogen Inorganic materials 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 11
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 229910052801 chlorine Inorganic materials 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 230000008034 disappearance Effects 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- 125000001309 chloro group Chemical group Cl* 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 4
- 229940073608 benzyl chloride Drugs 0.000 description 4
- JGJLWPGRMCADHB-UHFFFAOYSA-N hypobromite Chemical compound Br[O-] JGJLWPGRMCADHB-UHFFFAOYSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000001632 sodium acetate Substances 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- BAPJBEWLBFYGME-UHFFFAOYSA-N acrylic acid methyl ester Natural products COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- OPVHABJLWKXUNK-UHFFFAOYSA-N 7-phenylmethoxyquinolin-3-amine Chemical compound C1=CC2=CC(N)=CN=C2C=C1OCC1=CC=CC=C1 OPVHABJLWKXUNK-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FQQMHILHJQJWGI-UHFFFAOYSA-N C(C1=CC=CC=C1)OC1=CC=C2C=C(C(=NC2=C1)Cl)C=O Chemical compound C(C1=CC=CC=C1)OC1=CC=C2C=C(C(=NC2=C1)Cl)C=O FQQMHILHJQJWGI-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000005574 benzylation reaction Methods 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- DCFKHNIGBAHNSS-UHFFFAOYSA-N chloro(triethyl)silane Chemical compound CC[Si](Cl)(CC)CC DCFKHNIGBAHNSS-UHFFFAOYSA-N 0.000 description 2
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 description 2
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 description 2
- 229940112669 cuprous oxide Drugs 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 2
- 229910052808 lithium carbonate Inorganic materials 0.000 description 2
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 150000001467 thiazolidinediones Chemical class 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- QXSZNDIIPUOQMB-UHFFFAOYSA-N 1,1,2,2-tetrabromoethane Chemical compound BrC(Br)C(Br)Br QXSZNDIIPUOQMB-UHFFFAOYSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical class O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 description 1
- IPOQOPQRQIZMPS-UHFFFAOYSA-N 1-ethoxy-3-(trifluoromethoxy)propane Chemical compound CCOCCCOC(F)(F)F IPOQOPQRQIZMPS-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- JYHSJQNYYLGMEI-UHFFFAOYSA-N 3,3-dimethoxypropanenitrile Chemical compound COC(OC)CC#N JYHSJQNYYLGMEI-UHFFFAOYSA-N 0.000 description 1
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 1
- 229940018563 3-aminophenol Drugs 0.000 description 1
- KWSLGOVYXMQPPX-UHFFFAOYSA-N 5-[3-(trifluoromethyl)phenyl]-2h-tetrazole Chemical compound FC(F)(F)C1=CC=CC(C2=NNN=N2)=C1 KWSLGOVYXMQPPX-UHFFFAOYSA-N 0.000 description 1
- NMZUJUFGQKWJPT-UHFFFAOYSA-N 7-phenylmethoxyquinoline-3-carbonitrile Chemical compound C(C1=CC=CC=C1)OC1=CC=C2C=C(C=NC2=C1)C#N NMZUJUFGQKWJPT-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 241000238558 Eucarida Species 0.000 description 1
- RXKMOPXNWTYEHI-RDRKJGRWSA-N Flunarizine hydrochloride Chemical class Cl.Cl.C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)N1CCN(C\C=C\C=2C=CC=CC=2)CC1 RXKMOPXNWTYEHI-RDRKJGRWSA-N 0.000 description 1
- 101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical class CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229940123464 Thiazolidinedione Drugs 0.000 description 1
- 101150046432 Tril gene Proteins 0.000 description 1
- 241000219977 Vigna Species 0.000 description 1
- 235000010726 Vigna sinensis Nutrition 0.000 description 1
- MQRWBMAEBQOWAF-UHFFFAOYSA-N acetic acid;nickel Chemical compound [Ni].CC(O)=O.CC(O)=O MQRWBMAEBQOWAF-UHFFFAOYSA-N 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001804 chlorine Chemical class 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 229940077239 chlorous acid Drugs 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 229940045803 cuprous chloride Drugs 0.000 description 1
- CDHICTNQMQYRSM-UHFFFAOYSA-N di(propan-2-yl)alumane Chemical compound CC(C)[AlH]C(C)C CDHICTNQMQYRSM-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- ALBYIUDWACNRRB-UHFFFAOYSA-N hexanamide Chemical compound CCCCCC(N)=O ALBYIUDWACNRRB-UHFFFAOYSA-N 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229940078494 nickel acetate Drugs 0.000 description 1
- LAIZPRYFQUWUBN-UHFFFAOYSA-L nickel chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Ni+2] LAIZPRYFQUWUBN-UHFFFAOYSA-L 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 102000045222 parkin Human genes 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229910001379 sodium hypophosphite Inorganic materials 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- CRWJEUDFKNYSBX-UHFFFAOYSA-N sodium;hypobromite Chemical compound [Na+].Br[O-] CRWJEUDFKNYSBX-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- DZLNHFMRPBPULJ-UHFFFAOYSA-N thioproline Chemical group OC(=O)C1CSCN1 DZLNHFMRPBPULJ-UHFFFAOYSA-N 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
Definitions
- the present invention relates to a method for producing a 2-halo-3 (3-quinolyl) propionic acid derivative.
- R represents a hydrogen atom or a lower alkyl group
- X represents a halogen atom
- the 2-halo-3- (3-quinolyl) propionic acid derivative represented by the following formula can be used as a synthetic intermediate for pharmaceuticals, agricultural chemicals, etc., and has an action to improve insulin resistance, especially blood glucose.
- 5 [(7-benzyloxy-13-quinolyl) methyl] —2,4-thiazolidinedione (hereinafter referred to as thiazolidinedione derivative), which is useful as an antihypertensive, blood lipid lowering agent, and visceral fat reducing agent It can be used as a synthetic intermediate.
- thiazolidinedione derivative [(7-benzyloxy-13-quinolyl) methyl] —2,4-thiazolidinedione (hereinafter referred to as thiazolidinedione derivative), which is useful as an antihypertensive, blood lipid lowering agent, and visceral fat reducing agent It can be used as a synthetic intermediate.
- the present inventors have used 7-benzyloxy 12-halo-3-quinoline carbaldehyde or 7-hydroxy-13-quinoline ditrile as a starting material, and have a simple method and have a good yield.
- the present inventors have found a method for obtaining a 2-halo 3 _ (3-quinolyl) propionic acid derivative at a rate, and have completed the present invention.
- R represents a hydrogen atom or a lower alkyl group.
- the present invention relates to a method for producing a 2-halo-3- (3-quinolyl) propionic acid derivative represented by the formula: ⁇ Law B>
- a base and a halogen or hypohalogenate are allowed to act on a 3-quinolinecarboxamide derivative represented by the following general formula (V):
- the present invention relates to a method for producing a 2-halo-3- (3-quinolyl) propionic acid derivative represented by the formula: Further, the present invention provides a compound represented by the general formula (II):
- the present invention relates to a 3- (3-quinolyl) propionic acid derivative represented by the following formula:
- R 1 represents a hydrogen atom or a benzyl group
- R 2 represents a cyano group or a carbamoyl group.
- 2-Halo 3- (3-quinolyl) propionic acid derivative represented by the above general formula (I) In a conductor, a 3- (3-quinolyl) propionic acid derivative represented by the above general formula (e1) and a 3- (3-quinolyl) acrylic acid derivative represented by the above general formula (ill) And R is a hydrogen atom or a lower alkyl group having 1 to 6 carbon atoms such as a methyl group or an ethyl group.
- X is a halogen atom such as a chlorine atom, a bromine atom or an iodine atom.
- the halogen represented by Z examples include a chlorine atom, a bromine atom and an iodine atom, and a chlorine atom is preferable.
- the 3- (3-quinolinyl) acrylic acid derivative represented by the general formula (ill) and the 3-quinoline carbaldehyde derivative represented by the general formula (IV) the quinoline ring It is preferable that a certain benzyloxy group is substituted at the 7-position.
- the benzyloxy group on the quinoline ring is in the 7-position.
- the substitution position of RiO— is preferably 7-position of the quinoline ring.
- the 2-halo 3- (3-quinolyl) propionic acid derivative represented by the general formula (I) and the 3- (3-quinolyl) propionic acid derivative represented by the general formula (II) A 3- (3-quinolyl) acrylic acid derivative represented by the general formula (ill), a 3-quinoline carbaldehyde derivative represented by the general formula (IV), and a A 3-quinoquinoline derivative represented by the above general formula (VII) wherein R 1 is a benzyl group (a 3-quinolinecarboxamido derivative represented by the above general formula (VI))
- Toxic, ethoxy, propoxy, trifluor Carbon number 1-6 alkoxy group such as a main butoxy group, a methyl group, Echiru group, It may have a substituent such as an alkyl group having 1 to 6 carbon atoms such as propyl group and trifluoromethyl.
- This reaction is carried out under an atmosphere of argon or nitrogen in a solvent such as THF, DMSO, DMF or HMPA (hexamethylphosphoric triamide), LDA (lithium diisopropyl amide), lithium isoprobicyclo.
- a solvent such as THF, DMSO, DMF or HMPA (hexamethylphosphoric triamide), LDA (lithium diisopropyl amide), lithium isoprobicyclo.
- a solvent such as THF, DMSO, DMF or HMPA (hexamethylphosphoric triamide), LDA (lithium diisopropyl amide), lithium isoprobicyclo.
- a solvent such as THF, DMSO, DMF or HMPA (hexamethylphosphoric triamide), LDA (lithium diisopropyl amide), lithium isoprobicyclo.
- an organic lithium such as hexylamide, n-butyllithium or sec-butyllithium, or
- the 3- (3-quinolyl) propionic acid derivative represented by the above general formula (II) is a 3- (3-quinolyl) acrylic acid derivative represented by the above general formula (ill).
- Lower alcohols such as methanol, ethanol and isopropanol, and solvents such as THF, dioxane, DMSO or DMF (dimethylformamide), iron chloride, nickel chloride, cobalt chloride, zinc chloride, nickel acetate , Sodium hypophosphite, sodium hydride, sodium borohydride, diisopropylaluminum hydride, sodium cyanoborohydride in the presence of a metal catalyst such as palladium carbon
- a metal catalyst such as palladium carbon
- the 3- (3-quinolyl) propionic acid derivative represented by the above general formula (II) The compound is prepared by converting a 3- (3-quinolyl) acrylic acid derivative represented by the above general formula (ill) into a solvent such as hydrochloric acid or acetic acid, a metal such as Sn, Fe, ⁇ , or a neutral compound. conditions, Ri by the exerting a metal M g, or base under conditions that Njiru groups are not eliminated, can be obtained even if particular cowpea performing catalytic hydrogenation reduction.
- the 3- (3-quinolyl) propionic acid derivative represented by the general formula (II) is a derivative of the 3- (3-quinolyl) acrylic acid derivative represented by the general formula (ill). It can also be obtained by converting the chlorine atom at the 2-position to another substituent such as a bromine atom or an iodine atom, and then applying the above-described reduction reaction.
- the 3- (3-quinolyl) acrylic acid derivative represented by the general formula (ill) is obtained by adding THF, DMS ⁇ , DMF, dioxane to the 3-quinolinecarbaldehyde derivative represented by the general formula (IV). Or, in a solvent such as 1,2-dimethoxane or the like, in the presence of a base such as sodium hydride, alkyl lithium or sodium methoxide, and a dihydroquinone such as methyl dimethyl acetate. (Wittig) can be obtained by acting a reagent.
- the 3-quinolinecarbaldehyde derivative represented by the general formula (IV) is represented by the following general formula (XI): Can be obtained by allowing phosphorus oxychloride and DMF to act on the acetoanilide derivative represented by
- a method for obtaining the 3-aminoquinoline derivative represented by the general formula (V) from the 3-quinolincarpoxamide derivative represented by the general formula (VI) is a method for dissolving dioxane, water, or the like.
- sodium hydroxide, hydroxide hydroxide, barium hydroxide, sodium methoxide, sodium hydroxide are added to the 3—quinolinecarboxamide derivative represented by the general formula (vi).
- halogens such as bromine and chlorine
- sodium hypobromite, hypohalites such as sodium hypochlorite, or hypobromite
- hypohalous acid such as chlorous acid.
- the method for obtaining a 2-halo-3- (3-quinolyl) propionic acid derivative represented by the general formula (I) from a 3-aminoquinoline derivative represented by the general formula (V) is represented by the general formula (V)
- a hydrohalic acid such as aqueous hydrogen bromide or concentrated hydrochloric acid
- the reaction is carried out by diazotizing by reacting with um, and then reacting the alkyl acrylate in the presence of a copper catalyst (cuprous oxide, cuprous chloride).
- the 3-quinolinecarboxamide derivative represented by the general formula (VI) can be obtained by the following synthesis route.
- the 3-quinolinitritol derivative of the general formula (VIII) is heated with a base such as sodium hydroxide or sodium hydroxide under heating (preferably, the reaction is carried out by heating to reflux) or subjecting to a hydrolysis reaction.
- a base such as sodium hydroxide or sodium hydroxide under heating
- a 3-quinolinitrile derivative of the formula (X) and a benzyl halide such as benzyl chloride are heated (preferably). Or under reflux with heating).
- Methyl 3- (7-benzyloxy-3-3-quinolyl) propionate Methyl 3- (7-benzyloxy-2-chloro-3-quinolinyl) acrylate obtained in Example 2 (180 mg, 0.1 mg).
- 51 mmol) and nickel chloride hexahydrate (24 mg, 0.1 mmol) are suspended in a mixed solvent of dimethylformamide / methanol (1.5 mL / 1.5 mL). Then, the mixture was cooled on ice to keep the internal temperature at 10 ° C or less.
- sodium borohydride (10 O mg, 2.64 mmol) was slowly added over 10 minutes. After stirring for 3 hours under the same conditions, the mixture was returned to room temperature and stirred for 10 hours.
- 3,3-Dimethoxypropionitrile (91% content, 12.7, 0.10 mo1) was dissolved in toluene (60 mL), and sodium methoxide (6.48) was dissolved. g, 0.12 m 01), and then methyl formate (12.3 mL, 0.20 m 01) was added dropwise while maintaining the internal temperature at 30 to 35 ° C. After the addition was completed, the mixture was further stirred at room temperature for 22 hours. Next, a mixture of concentrated hydrochloric acid (26.7 mL, 0, 32 mol) and methanol (30 mL) was added dropwise over 5 minutes under ice cooling, and the temperature was returned to room temperature for 30 minutes. Stirred.
- 3-Amino 7-benzyloxyquinoline (2.3 g, 9.2 mimol) was dissolved in a mixed solvent of acetate and water (25 mL / 6 mL). After that, concentrated hydrochloric acid (2. 5 mL) was added. After the reaction temperature was lowered to 5 ° C. or lower, an aqueous solution of sodium nitrite (833 mg (12 mmol) /1.6 mL) was added over 5 minutes. After maintaining the reaction temperature at 5 ° C and stirring for 20 minutes, methyl acrylate (6 mL, 67.5 millimol) was added over 5 minutes. Then, cuprous oxide (120 mg) was slowly added, and the reaction temperature was increased to 37 ° C, followed by vigorous stirring under the same conditions for 1 hour.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU34551/00A AU3455100A (en) | 1999-05-28 | 2000-03-30 | Process for the preparation of 2-halo-3-(3-quinolyl)propionic acid derivatives |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14895699 | 1999-05-28 | ||
JP11/148957 | 1999-05-28 | ||
JP14895799 | 1999-05-28 | ||
JP11/148956 | 1999-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000073273A1 true WO2000073273A1 (fr) | 2000-12-07 |
Family
ID=26478992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2000/002001 WO2000073273A1 (fr) | 1999-05-28 | 2000-03-30 | Procede d'obtention de derives 2-halo-3-(3-quinolyl) acide proprionique |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3455100A (fr) |
WO (1) | WO2000073273A1 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06145146A (ja) * | 1992-11-06 | 1994-05-24 | Chisso Corp | オキシネイト誘導体 |
EP0787725A1 (fr) * | 1994-10-20 | 1997-08-06 | Nippon Chemiphar Co., Ltd. | Derive de quinoline |
WO1998020871A1 (fr) * | 1996-11-08 | 1998-05-22 | Nippon Chemiphar Co., Ltd. | Agent diminuant la graisse viscerale |
WO1998028254A1 (fr) * | 1996-12-24 | 1998-07-02 | Nippon Chemiphar Co., Ltd. | Derives d'acide propionique |
WO1998028305A1 (fr) * | 1996-12-20 | 1998-07-02 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Nouveaux analogues de la camptothecine, leur application comme medicaments et les compositions pharmaceutiques les contenant |
-
2000
- 2000-03-30 WO PCT/JP2000/002001 patent/WO2000073273A1/fr active Application Filing
- 2000-03-30 AU AU34551/00A patent/AU3455100A/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06145146A (ja) * | 1992-11-06 | 1994-05-24 | Chisso Corp | オキシネイト誘導体 |
EP0787725A1 (fr) * | 1994-10-20 | 1997-08-06 | Nippon Chemiphar Co., Ltd. | Derive de quinoline |
WO1998020871A1 (fr) * | 1996-11-08 | 1998-05-22 | Nippon Chemiphar Co., Ltd. | Agent diminuant la graisse viscerale |
WO1998028305A1 (fr) * | 1996-12-20 | 1998-07-02 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Nouveaux analogues de la camptothecine, leur application comme medicaments et les compositions pharmaceutiques les contenant |
WO1998028254A1 (fr) * | 1996-12-24 | 1998-07-02 | Nippon Chemiphar Co., Ltd. | Derives d'acide propionique |
Non-Patent Citations (2)
Title |
---|
CHEMICAL ABSTRACTS, vol. 66, 1967, Columbus, Ohio, US; abstract no. 55355N, ZYMALKOWSKI,F.: "Quinolines,IsoQuinolines,and other 6-Membered rings" page 5223; XP002929656 * |
LIEBIGS ANN. CHEM, vol. 699, 1966, pages 98 - 106 * |
Also Published As
Publication number | Publication date |
---|---|
AU3455100A (en) | 2000-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2004518737A (ja) | 2−(4−クロロベンゾイルアミノ)−3−[2(1h)−キノールリノン−4−イル]プロピオン酸の製造方法 | |
US20040176614A1 (en) | Process for the preparation of indole derivatives and intermediates of the process | |
JP4656604B2 (ja) | イノシン誘導体及びその製造方法 | |
WO2000073273A1 (fr) | Procede d'obtention de derives 2-halo-3-(3-quinolyl) acide proprionique | |
JP4496586B2 (ja) | キノリルアクリロニトリルの製造法及びその中間体 | |
AU670708B2 (en) | Palladium catalyzed vinylic substitution reactions with 2-substituted-pyridines | |
JP4026233B2 (ja) | 4,5−ジクロロ−6−(α−フルオロアルキル)ピリミジンの製法 | |
JP4305597B2 (ja) | 弗素置換安息香酸の製造法 | |
JP4433365B2 (ja) | 4−(2−メチル−1−イミダゾリル)−2,2−ジフェニルブタンアミドの製造方法 | |
JPH10226683A (ja) | 2−(10,11−ジヒドロ−10−オキソジベンゾ[b,f]チエピン−2−イル)プロピオン酸の製造方法、及びその中間体化合物 | |
WO2001070747A1 (fr) | Procede de production de camptothecine | |
JP3002043B2 (ja) | キノリニウム塩およびその製造方法 | |
US20040102639A1 (en) | Preparation of isocoumarin derivatives and intermediates for the synthesis thereof | |
JPH10139768A (ja) | ナフタレン誘導体の製造方法 | |
JP4902247B2 (ja) | 2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体 | |
JP3020040B2 (ja) | 2−オキソ−5−ヒドロキシクロマンの製造方法 | |
JPH0873454A (ja) | シクロヘプトイミダゾ−ル誘導体の製造法 | |
US5646286A (en) | Palladium catalyzed vinylic substitution reactions with 2-substituted-pyridines | |
JP3982645B2 (ja) | N−置換ジオキソチアゾリジルベンズアミド誘導体の製造中間体 | |
JP2001158774A (ja) | 6−トリフルオロメチルニコチン酸類の製造方法 | |
JPH0597883A (ja) | インドール誘導体 | |
JP3061599B2 (ja) | ケトン類の製造法 | |
JP4496585B2 (ja) | キノリルプロペナールの製造方法 | |
CN119775219A (zh) | 二苯基三嗪类化合物中间体及其合成方法和应用 | |
KR900003529B1 (ko) | 2-아실-3,4-디알콕시아닐린의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 621339 Kind code of ref document: A Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |